skip to main content
10.1145/3473258.3473278acmotherconferencesArticle/Chapter ViewAbstractPublication PagesicbbtConference Proceedingsconference-collections
research-article

Construction of Dysregulated lncRNA-Associated ceRNA Network in Atrial Fibrillation

Authors Info & Claims
Published:11 December 2021Publication History

ABSTRACT

Enough evidence has revealed that competing endogenous RNAs (ceRNAs) activity of long non-coding RNAs (lncRNAs) plays an important role in pathological processes of human diseases including cardiovascular diseases. However, the role of lncRNA in atrial fibrillation (AF) and their implications still remain unclear to date. In this study, lncRNA-mRNA network related to AF was constructed based on the ceRNA theory. We first obtained lncRNAs with topological characteristics in the lncRNA-mRNA network. We then construct a co-expression network to identify the lncRNA-associated functions, and the mRNAs in the network were analyzed for the enriched pathways which showed that the pathways were related to AF. We then analyzed the dysregulation of lncRNA-mRNA in ceRNA network and obtained three lncRNAs as hub lncRNAs. The obtained results indicate that lncRNAs might exert the pathogenesis of AF. This might help in the understanding of molecular mechanisms of lncRNA in AF, providing novel lncRNAs as potential biomarkers and/or therapeutic targets.

Skip Supplemental Material Section

Supplemental Material

References

  1. C. Qian, H. Li, D. Chang, B. Wei, and Y. Wang, “Identification of functional lncRNAs in atrial fibrillation by integrative analysis of the lncRNA ‐ mRNA network based on competing endogenous RNAs hypothesis,” J Cell Physiol., vol. 234, no. 7, pp. 11620–11630, 2019.Google ScholarGoogle ScholarCross RefCross Ref
  2. Z. Wang, Y. Lu, and B. Yang, “MicroRNAs and atrial fibrillation: New fundamentals,” Cardiovasc. Res., vol. 89, no. 4, pp. 710–721, 2011.Google ScholarGoogle ScholarCross RefCross Ref
  3. Y. Zhang, X. Ke, J. Liu, X. Ma, and Y. I. Liu, “Characterization of circRNA ‑ associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation,” Mol. Med. Rep., vol. 19, pp. 638–650, 2019.Google ScholarGoogle Scholar
  4. J. L. Santos, I. Rodríguez, M. S. Olesen, B. H. Bentzen, and N. Schmitt, “Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation,” PLoS One, vol. 15, no. 5, pp. 1–21, 2020.Google ScholarGoogle Scholar
  5. J. Wu, D. Han, R. Shi, M. Chen, J. Sun, and H. Tian, “Identification of atrial fibrillation-associated lncRNAs in atria from patients with rheumatic mitral valve disease,” Microsc. Res. Tech., vol. 82, no. 7, pp. 1136–1144, 2019.Google ScholarGoogle ScholarCross RefCross Ref
  6. T. Sallam, J. Sandhu, and P. Tontonoz, “Long noncoding RNA discovery in cardiovascular disease: Decoding form to function,” Circ Res, vol. 122, no. 1, pp. 155–166, 2018.Google ScholarGoogle ScholarCross RefCross Ref
  7. Y. Tay, J. Rinn, and P. P. Pandolfi, “The multilayered complexity of ceRNA crosstalk and competition,” Nature, vol. 505, pp. 344–352, 2014.Google ScholarGoogle ScholarCross RefCross Ref
  8. V. Agarwal, G. W. Bell, J. Nam, and D. P. Bartel, “Predicting effective microRNA target sites in mammalian mRNAs,” Elife, vol. 4, pp. 1–38, 2015.Google ScholarGoogle ScholarCross RefCross Ref
  9. Y. Chen and X. Wang, “miRDB: an online database for prediction of functional microRNA targets,” Nucleic Acids Res., vol. 48, pp. 127–131, 2020.Google ScholarGoogle ScholarCross RefCross Ref
  10. H. Huang , “miRTarBase 2020: updates to the experimentally validated microRNA – target interaction database,” Nucleic Acids Res., vol. 48, pp. 148–154, 2020.Google ScholarGoogle Scholar
  11. G. Wang , “Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences,” PLoS One, vol. 14, no. 9, pp. 1–16, 2019.Google ScholarGoogle ScholarCross RefCross Ref
  12. Z. Fan , “Integrative analysis of competing endogenous RNA networks reveals the functional lncRNAs in heart failure,” J Cell Mol Med., vol. 22, no. 10, pp. 4818–4829, 2018.Google ScholarGoogle ScholarCross RefCross Ref
  13. X. Tian, Y. Ji, Y. Liang, J. Zhang, C. Wang, and L. Guan, “LINC00520 targeting miR ‐ 27b ‐ 3p regulates OSMR expression level to promote acute kidney injury development through the PI3K / AKT signaling pathway,” J Cell Physiol., vol. 234, no. 8, pp. 14221–14233, 2019.Google ScholarGoogle ScholarCross RefCross Ref
  14. P. Monteiro, M. Bennett, J. Rodor, I. Ulitsky, and A. H. Baker, “Endothelial function and dysfunction in the cardiovascular system: the long non-coding road,” Cardiovasc. Res., vol. 115, pp. 1692–1704, 2019.Google ScholarGoogle ScholarCross RefCross Ref
  15. C. Menni , “Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts,” Circ. Res., vol. 122, no. 11, pp. 1555–1564, 2018.Google ScholarGoogle ScholarCross RefCross Ref
  16. J. Kornej , “Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade,” PLoS One, vol. 13, no. 11, pp. 1–10, 2018.Google ScholarGoogle ScholarCross RefCross Ref
  17. K.-V. Tran , “Circulating extra-cellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome,” J. Clin. Transl. Res., vol. 5, no. 1, pp. 33–43, 2019.Google ScholarGoogle Scholar
  18. Z. G. Liang, H. Yao, R. S. Xie, C. L. I. N. Gong, and Y. E. Tian, “MicroRNA ‑ 20b ‑ 5p promotes ventricular remodeling by targeting the TGF ‑ β / Smad signaling pathway in a rat model of ischemia ‑ reperfusion injury,” Int. J. Mol. Med. Med., vol. 42, no. 2, pp. 975–987, 2018.Google ScholarGoogle Scholar
  19. C. Khuu, A. Jevnaker, M. Bryne, and H. Osmundsen, “An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes,” Front. Genet., vol. 5, pp. 1–14, 2014.Google ScholarGoogle ScholarCross RefCross Ref

Recommendations

Comments

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Sign in
  • Published in

    cover image ACM Other conferences
    ICBBT '21: Proceedings of the 2021 13th International Conference on Bioinformatics and Biomedical Technology
    May 2021
    293 pages
    ISBN:9781450389655
    DOI:10.1145/3473258

    Copyright © 2021 ACM

    Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    • Published: 11 December 2021

    Permissions

    Request permissions about this article.

    Request Permissions

    Check for updates

    Qualifiers

    • research-article
    • Research
    • Refereed limited
  • Article Metrics

    • Downloads (Last 12 months)3
    • Downloads (Last 6 weeks)0

    Other Metrics

PDF Format

View or Download as a PDF file.

PDF

eReader

View online with eReader.

eReader

HTML Format

View this article in HTML Format .

View HTML Format